Timing of Antibiotic Administration in Pediatric Sepsis

Jessica K Creedon1, Sigella Vargas1, Lisa A Asaro1

  • 1From the Boston Children's Hospital, Boston, MA.

Pediatric Emergency Care
|November 30, 2018
PubMed

Insights

Early antibiotics in children with sepsis who develop septic shock may increase mortality and organ dysfunction. This study found that administering antibiotics within one hour of meeting sepsis criteria was associated with worse outcomes.

Area of Science:

  • Pediatric critical care medicine
  • Infectious diseases
  • Sepsis research

Background:

  • Early antibiotic administration is crucial for reducing mortality in sepsis.
  • The impact of early antibiotics on outcomes in pediatric septic shock remains unclear.

Purpose of the Study:

  • To investigate the association between the timing of antibiotic administration and outcomes in children with septic shock.
  • To determine if antibiotics given within one hour of meeting sepsis criteria affect morbidity and mortality.

Main Methods:

  • Retrospective study of children (≤18 years) with sepsis progressing to septic shock.
  • Data collected from a tertiary children's hospital emergency department (2008-2012).
  • Assessed time from sepsis criteria to first antibiotic dose and correlated with outcomes.

Main Results:

  • Children receiving antibiotics within 1 hour of sepsis criteria had higher mortality (4/42 vs 0/93).
  • This group also experienced increased organ dysfunction, longer vasoactive infusion duration, and extended ICU/hospital stays.
  • Positive blood/urine cultures and pneumonia were noted in a subset of patients.

Conclusions:

  • Administering antibiotics within 1 hour of meeting sepsis criteria in children who develop septic shock is associated with increased mortality.
  • Early antibiotic administration in this context also correlates with greater organ dysfunction and longer hospitalizations.
Abstract

Related Concept Videos

Antibiotic Selection00:57

Antibiotic Selection

Overview
59.9K
Development of Antibiotic Resistance01:30

Development of Antibiotic Resistance

Antibiotic resistance is a major public health concern that arises when bacteria evolve mechanisms to withstand the effects of antibiotic treatments. This resistance can be intrinsic, acquired through genetic mutations, or transferred between bacteria via horizontal gene transfer. The development of antibiotic resistance poses significant challenges in treating bacterial infections and necessitates ongoing research to develop new therapeutic strategies.Intrinsic resistance occurs when bacterial...
1.5K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
261
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
307
Pharmacokinetics in Pediatric Patients: Drug Metabolism01:24

Pharmacokinetics in Pediatric Patients: Drug Metabolism

In pediatric care, understanding the nuances of hepatic drug metabolism is crucial, as it significantly differs from that of adults. This divergence is primarily due to the developmental stage of drug-metabolizing enzymes, which affects how medications are processed in the body. In neonates, for instance, the activity of Phase I enzymes—critical for the initial breakdown of drugs—is markedly reduced, functioning at just 20–40% of the levels seen in adults. This reduction poses...
227
Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption01:23

Pharmacokinetics in Pediatric Patients: Overview and Drug Absorption

Understanding the physiological differences in the pediatric population is crucial for effective pharmacotherapy. Neonates, infants, and children exhibit significant variations in gastric pH, gastric emptying time, intestinal transit time, and biliary function. These variations profoundly affect oral drug absorption, necessitating a nuanced approach to pediatric dosing.Neonates present with a unique physiological profile, having a gastric pH greater than 4 and faster and more irregular gastric...
298